Cost-effectiveness league tables: more harm than good?
- PMID: 8332922
- DOI: 10.1016/0277-9536(93)90315-u
Cost-effectiveness league tables: more harm than good?
Abstract
In recent years it has become fashionable to make comparisons (in 'league tables' or rankings) between health care interventions in terms of their relative cost-effectiveness, in cost per life-year or cost per quality-adjusted life-year gained. However, concerns have been raised about the unthinking use of league tables and some authors have questioned the theoretical basis of their construction. In this paper a recently-reported league table is scrutinized and the important methodological features of the source studies identified. These include the choice of discount rate, the method of estimating utility values for health states, the range of costs and consequences considered and the choice of comparison programme. Several recommendations are made for improvements, both in the methodology of economic evaluation studies and in the construction and use of league tables. It is concluded that, for league tables to be useful, decision makers should be able to assess the relevance and reliability of the evidence in their own setting. Fuller reporting of methods and results by the authors of economic evaluation studies would greatly assist in the appropriate construction and use of league tables.
Similar articles
-
Cost-effectiveness league tables: valuable guidance for decision makers?Pharmacoeconomics. 2003;21(14):991-1000. doi: 10.2165/00019053-200321140-00001. Pharmacoeconomics. 2003. PMID: 13129413
-
Some guidelines on the use of cost effectiveness league tables.BMJ. 1993 Feb 27;306(6877):570-2. doi: 10.1136/bmj.306.6877.570. BMJ. 1993. PMID: 8461776 Free PMC article.
-
Cost-per-QALY league tables: their role in pharmacoeconomic analysis.Pharmacoeconomics. 1994 Jun;5(6):472-81. doi: 10.2165/00019053-199405060-00004. Pharmacoeconomics. 1994. PMID: 10147264
-
Cost-effectiveness ratios: in a league of their own.Health Policy. 1994 May;28(2):133-41. doi: 10.1016/0168-8510(94)90031-0. Health Policy. 1994. PMID: 10136058 Review.
-
QALY league tables: handle with care.Health Econ. 1993 Apr;2(1):59-64. doi: 10.1002/hec.4730020108. Health Econ. 1993. PMID: 8269048 Review.
Cited by
-
Thresholds for the cost-effectiveness of interventions: alternative approaches.Bull World Health Organ. 2015 Feb 1;93(2):118-24. doi: 10.2471/BLT.14.138206. Epub 2014 Dec 15. Bull World Health Organ. 2015. PMID: 25883405 Free PMC article.
-
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).Pharmacoeconomics. 2001;19(11):1103-9. doi: 10.2165/00019053-200119110-00004. Pharmacoeconomics. 2001. PMID: 11735677
-
A risk-adjusted approach to comparing the return on investment in health care programs.Int J Health Care Finance Econ. 2004 Sep;4(3):199-210. doi: 10.1023/B:IHFE.0000036046.80562.06. Int J Health Care Finance Econ. 2004. PMID: 15277778
-
Comments on economic evaluation of chemotherapy.Pharmacoeconomics. 1997 Aug;12(2 Pt 1):229-31. doi: 10.2165/00019053-199712020-00011. Pharmacoeconomics. 1997. PMID: 10169673 No abstract available.
-
QALYs: are they helpful to decision makers?Pharmacoeconomics. 2006;24(10):947-52. doi: 10.2165/00019053-200624100-00002. Pharmacoeconomics. 2006. PMID: 17002477
Publication types
MeSH terms
LinkOut - more resources
Medical